Category Archives: Hockey
(Editor’s Note: What follows is an excerpt from “Bauer Hockey Reaches Settlement with Canada’s Competition Bureau over Advertising Claims,” which appeared in the December issue of Concussion Litigation Reporter)
Bauer Hockey Corp. has reached a settlement to resolve an inquiry by Canada’s Competition Bureau regarding certain aspects of its advertising for the BAUER RE-AKT Helmet.
Specifically, the Bureau requested that Bauer remove or modify certain existing performance claims in Canada regarding the helmet. As part of the settlement, Bauer Hockey has also agreed to donate $500,000 worth of sports equipment to a Canadian charity over the course of five years.
Mike Oliver, the executive director of the National Operating Committee on Standards for Athletic Equipment (NOCSAE), told Concussion Litigation Reporter that “the premise underlying the decision is both reasonable and accurate with regard to what helmets can and can’t do, and as to the level of scientific proof that should accompany any claim of measurable improvement to concussion protection.”
He continued: “There are far too many anecdotal stories offered as proof that certain products protect against concussive injuries. This decision mandates a much higher and verifiable level of evidential proof if such claims are to be made. Emotions run high on all sides of the concussion discussion. Parents worry about the long-term consequences of a concussive injury, and are easy targets for a simple solution. Imposing an objective and strict proof requirement recognizes the potential for misplaced reliance and should effectively limit such unsupported claims.”
(To read the rest of the story, which includes an interview with a legal expert, subscribe to CLR)
By Joe Kullman, of the Ira A. Fulton Schools of Engineering at Arizona State University
Traumatic brain injury is currently revealed by using a series of physiological and cognitive tests along with standard medical imaging, such as magnetic resonance imaging (MRI). The techniques are excellent for diagnosis of moderate to severe traumatic brain injury, but less effective for diagnosing mild injury and for predicting the extent of its impact.
When approaching the problem from an engineering standpoint, one element missing from the diagnostic tool kit is the ability to detect signs of brain injury at the molecular and cellular levels.
Biomedical engineer Sarah Stabenfeldt has received the National Institutes of Health Director’s New Innovator Award to support her work to develop such molecular tools. The award is designed to support creative investigators who propose innovative projects with high-impact potential.
Stabenfeldt is an assistant professor in the School of Biological and Health systems Engineering, one the Ira A. Fulton Schools of Engineering at Arizona State University.
More than 1.7 million people in the United States sustain traumatic brain injury each year, according to the Centers for Disease Control and Prevention.
Stabenfeldt has been studying possibilities of using nanoscale devices for enhanced detection and treatment of brain injuries ranging from mild to severe.
She is exploring the use of engineered nanobodies for this purpose. Nanobodies are therapeutic proteins derived from antibodies that contain structural and functional properties of naturally occurring antibodies. Antibodies are proteins produced by plasma cells that are used by the body’s immune system to identify and remove or neutralize harmful bacteria and viruses.
Her goal is to develop a nanoparticle system decorated with nanobodies that can be introduced into the bloodstream as “targeting probes” that have the ability to locate the molecular and cellular source of brain damage. Stabenfeldt describes the probes as similar to balls with Velcro or suction cups on them, facilitating the nanoparticles to attach themselves to the injured areas in the brain.
Once attached, they would then serve a multitude of functions ranging from diagnostic contrast agent for medical imaging to delivering doses of medicinal drugs to the area – drugs that would jump-start the healing process.
“The ability of nanobody probes to recognize the complexity and severity of neural injury to the brain at the molecular level has the potential to significantly impact diagnostic and therapeutic approaches for traumatic brain injury,” Stabenfeldt said.
The project is a complex undertaking that will require a range of biomedical and technical skills. The National Institutes of Health likely considered the diverse expertise of her colleagues in the Fulton Schools of Engineering in deciding to support her research, Stabenfeldt said.
She will be collaborating with three fellow faculty members: assistant professor Vikram Kodibagkar, associate professor Jeffrey Kleim and professor Michael Sierks.
She will also work with medical professionals at the Barrow Neurological Institute at Phoenix Children’s Hospital: Dr. David Adelson, director of the institute, and Jonathan Lifshitz, director of the Translational Neurotrauma Research Program.
The grant is providing $2.3 million to fund her work for five years. Beyond covering laboratory expenses, it will enable Stabenfeldt to provide biomedical engineering doctoral students opportunities to assist in the research.
ABLE Act Passes Senate, Will Become Law and Help Those Kids Who Suffer Long-Term Effects of Concussions
Those who suffer debilitating concussions or brain injuries on the playing field will get some relief after the United States Senate passed the bipartisan Achieving a Better Life Experience (ABLE) Act earlier this week.
ABLE will make it easier for Americans with disabilities to save for their long-term care. The legislation, which has been described as, “the broadest legislation to help the disabled in nearly a quarter-century,” would allow families with children who have disabilities to open up 529-style tax-free savings accounts for them to build wealth and financial independence.
“Americans with disabilities deserve every opportunity to build a brighter future and the financial stability to ensure independence and self-determination,” said U.S. Senator Chris Coons (D-Del.), who was an original co-sponsor of the bill. “For too long, families of children with disabilities have faced the choice between federal benefits to help care for their child and saving for their child’s future. When the President signs the ABLE Act into law, families will be able to ensure their children will grow up with the means to provide for themselves while also meeting their current needs. They will no longer need to choose between their family’s present and their child’s future. The fight for the ABLE Act is one I’ve been proud to be a part of. I know many families in Delaware who will benefit from this law, and am proud to have played a small role in something that can make a huge difference in their lives.”